Hideyuki Okano Editor in Chief Inflammation and Regeneration Cover [ PDF(382KB)] |
Review Article
1.Molecular and cellular basis for cardiac regeneration |
334-340
|
I. Shiojima and I. Komuro
|
|
[PDF (135KB)] |
Special Issue: "Novel targeted therapies"
2.Recent progress in small molecular products for the treatment of joint and bone diseases: an over view |
341-343
|
Y. Tanaka and N. Miyasaka
|
|
[PDF (45KB)] |
3.Denosumab for the treatment of joint and bone diseases |
344-348
|
Y. Tanaka
|
|
[PDF (99KB)] |
4.JAK inhibitor: tofacitinib, a new disease modifying anti-rheumatic drug |
349-353
|
K. Yamaoka, S. Kubo, K. Sonomoto, K. Maeshima, and Y. Tanaka
|
|
[PDF (119KB)] |
5.Potential molecular targets for suppressing Th17 development |
354-360
|
K. Okamoto and H. Takayanagi
|
|
[PDF (354KB)] |
Mini Review
6.Immune cells and iPS cells |
361-364
|
H. Wada and K. Seino
|
|
[PDF (52KB)] |
7.Cytokines and chemokines as therapeutic targets for ischemic kidney injury |
365-369
|
K. Furuichi, T. Wada and S. Kaneko
|
|
[PDF (444KB)] |
8.Phospholipase Cε as a potential molecular target for anti-inflammatory therapy and cancer prevention |
370-374
|
H. Edamatsu, N. Takenaka, L. Hu and T. Kataoka
|
|
[PDF (92KB)] |
9.Effect of antimicrobial cathelicidin peptides on the endothelial cell apoptosis |
375-381
|
Kaori Suzuki and Isao Nagaoka
|
|
[PDF (182KB)] |